D-0597-2026 Class II Ongoing

Recalled by Ascend Laboratories, LLC — Bedminster, NJ

FDA drug recall D-0597-2026 was initiated by Ascend Laboratories, LLC on Jun 1, 2026 and is designated Class II. Reason for recall: Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis The recall status is ongoing. Affected quantity: 360 30-count bottles.

Recall details

Product Type
Drugs
Report Date
Jun 17, 2026
Initiation Date
Jun 1, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
360 30-count bottles

Product description

Minocycline Hydrochloride Extended-Release Tablets, USP, 115 mg, 30-count bottle, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA. Distributed by: Ascend Laboratories, LLC, Parsippany, NJ 07054. NDC: 67877-644-30

Reason for recall

Failed Dissolution Specifications: An out-of-specification (OOS) result was observed during the 9th month of dissolution test analysis

Distribution pattern

Nationwide in the USA

Code information

Lot# 25141635, Exp 4/30/2028

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0597-2026
openFDA file date
Nov 19, 2026
Loaded by RegDataLab
Nov 20, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Need the full FDA record for Ascend Laboratories, LLC? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Source: openFDA record for D-0597-2026. Report a data issue: hello@regdatalab.com.